European Economy Strikes at Rising Stars

Establishing oneself as an independent investigator is not easy, and this is especially true for young scientists in Europe. The good news is that in many European countries, substantial reforms and improvements have begun to reverse the brain drain. The bad news is that because of the economic slowdown, science funding is often being squeezed, and this always affects people at the junior end. Germany's Max Planck Society (MPG), for example, recently announced dramatic cuts to cope with a de

Written byMartina Habeck
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Establishing oneself as an independent investigator is not easy, and this is especially true for young scientists in Europe. The good news is that in many European countries, substantial reforms and improvements have begun to reverse the brain drain. The bad news is that because of the economic slowdown, science funding is often being squeezed, and this always affects people at the junior end.

Germany's Max Planck Society (MPG), for example, recently announced dramatic cuts to cope with a decreased annual budget. Not only will the society close several research departments and an entire institute; members also decided to cancel 15 (almost one-third) of their independent junior research groups at the end of their five-year grants.

When spending must be reduced drastically, it is certainly easiest to cut the lowest members of the hierarchy. But becoming a group leader at a Max Planck Institute (MPI) is one of the most ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies